One of my favorite stocks right now is Adaptive Biotechnologies (NASDAQ: ADPT). You know how everybody and their mother is trying to find a cure for COVID-19? Here is how Adaptive is going about it: Instead of trying to decode this virus and understand its RNA, Adaptive is focusing on humans' immune response to it.
How is it that some people can catch COVID-19 and have no symptoms? Adaptive wants to solve that mystery. And the company believes that if it can figure out how an immune system successfully responds to this virus, it will help us detect COVID-19, treat it, and maybe even provide a cure.
Image source: Getty Images